Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease.
Füller D, Liu C, Ko YA, Alkhoder AA, Desai SR, Almuwaqqat Z, Patel SA, Ejaz K, Kauser T, Martini MA, Alvi Z, Mehta PK, Sperling LS, Quyyumi AA. Füller D, et al. Among authors: martini ma. Eur J Prev Cardiol. 2024 Mar 27;31(5):521-528. doi: 10.1093/eurjpc/zwad311. Eur J Prev Cardiol. 2024. PMID: 37788634
Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease.
Kelli HM, Mehta A, Tahhan AS, Liu C, Kim JH, Dong TA, Dhindsa DS, Ghazzal B, Choudhary MK, Sandesara PB, Hayek SS, Topel ML, Alkhoder AA, Martini MA, Sidoti A, Ko YA, Lewis TT, Vaccarino V, Sperling LS, Quyyumi AA. Kelli HM, et al. Among authors: martini ma. J Am Heart Assoc. 2019 Sep 3;8(17):e013165. doi: 10.1161/JAHA.119.013165. Epub 2019 Sep 2. J Am Heart Assoc. 2019. PMID: 31476920 Free PMC article.
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease.
Mehta A, Desai SR, Ko YA, Liu C, Dhindsa DS, Nayak A, Hooda A, Martini MA, Ejaz K, Sperling LS, Reiser J, Hayek SS, Quyyumi AA. Mehta A, et al. Among authors: martini ma. J Am Heart Assoc. 2020 Mar 3;9(5):e015457. doi: 10.1161/JAHA.119.015457. Epub 2020 Feb 22. J Am Heart Assoc. 2020. PMID: 32089048 Free PMC article.
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
Mehta A, Mavromatis K, Ko YA, Rogers SC, Dhindsa DS, Goodwin C, Patel R, Martini MA, Prasad M, Mokhtari A, Hesaroieh IG, Frohwein SC, Kutner MH, Harzand A, Wells BJ, Duwayri Y, Alabi O, Rajani RR, Brewster LP, Waller EK, Quyyumi AA. Mehta A, et al. Among authors: martini ma. Contemp Clin Trials. 2020 Apr;91:105975. doi: 10.1016/j.cct.2020.105975. Epub 2020 Mar 4. Contemp Clin Trials. 2020. PMID: 32145440 Free PMC article.
18 results